Israel's Oramed says oral insulin capsule trial a success

January 30, 2014 10:31 AM

10 0

Israel's Oramed says oral insulin capsule trial a success

JERUSALEM (Reuters) - Oramed, an Israeli developer of oral drug delivery systems, said on Thursday a mid-stage trial for its oral insulin capsule for the treatment of type 2 diabetes met all primary and secondary endpoints.

During the Phase 2a trial, conducted under a U.S. Food and Drug Administration new drug protocol, 30 patients with type 2 diabetes took part in an in-patient setting for one week.

Read more

To category page

Loading...